(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide
SIGMA/C2175 - ≥97% (HPLC), powder
Synonym: CCK-8; Cholecystokinin octapeptide; Pancreozymin C-terminal octapeptide; Sincalide
CAS Number: 25126-32-3
Empirical Formula (Hill Notation): C49H62N10O16S3
Molecular Weight: 1143.27
EC Number: 246-639-0
MDL Number: MFCD00079849
Linear Formula: C49H62N10O16S3
Product Type: Chemical
| assay | ≥97% (HPLC) |
| form | powder |
| InChI | 1S/C49H62N10O16S3/c1-76-1 |
| InChI key | IZTQOLKUZKXIRV-IVVJSLGPSA |
| Quality Level | 200 ![]() |
| SMILES string | CSCC[C@H](NC(=O)[C@H](Cc1 |
| storage temp. | −20°C |
| UniProt accession no. | P06307 ![]() |
P30551 ![]() |
|
P30553 ![]() |
| Amino Acid Sequence: | Asp-Tyr-Met-Gly-Trp-Met-A |
| Application: | (Tyr[SO3H]27)Cholecystokinin fragment 26-33 amide has been used to test its effects: • to study its effects on β5i/LMP7 immunoproteasome subunit in pancreatitis • on gastric emptying,food intake and c-Fos immunoreactivity in small litter (SL) and normal litter (NL) rats • on the intestine and gallbladder motility in fish Ballan Wrasse |
| Biochem/physiol Actions: | (Tyr[SO3H]27)Cholecystokinin fragment 26-33 amide activates the cholecystokinin type B receptor and may mediate the blockage of opioid analgesia. It elicits anti-inflammatory effects. It mediates the inhibition on cytokine release, lymphocytes, and macrophages. |
| Biochem/physiol Actions: | Neurotransmitter; predominant form of CCK in CNS and gastrointestinal tract; may play a role in satiety. |
| General description: | (Tyr[SO3H]27)Cholecystokinin fragment 26-33 amide is a sulfated cholecystokinin(CCK) octapeptide derived from the proCCK. It is present in plasma and endocrine cells. |
| Other Notes: | C-Terminal octapeptide of cholecystokinin |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |

